Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

about

Engineered nanoparticles induce cell apoptosis: potential for cancer therapy Nanoinformatics knowledge infrastructures: bringing efficient information management to nanomedical research Metal-organic frameworks as potential drug delivery systems.

P2860

Q26750869-6932BDCB-93D8-40A3-809D-5BD0B3CEC38B Q28658443-6E49E879-5A97-4791-99AC-EB2D9DA9E28C Q38058895-4B1BBF52-079A-460B-9744-C3BFBF8C4B20

P2860

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

Item

http://www.wikidata.org/entity/Q38015511

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

@en

type

Item

label

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

@en

prefLabel

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

@en

P1476

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

@en

P2093

Andrew N Shelling

http://www.w3.org/2001/XMLSchema#string

Eshrat Gharaei Fathabadi

http://www.w3.org/2001/XMLSchema#string

Raida Al-Kassas

http://www.w3.org/2001/XMLSchema#string

P2860

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

Integrated genomic analyses of ovarian carcinoma

Therapeutic nanoparticles for drug delivery in cancer

RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9

Chemosensitization of cancer cells by siRNA using targeted nanogel delivery.

Targeting the EGF receptor for ovarian cancer therapy.

Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.

Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery.

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

KLF6-SV1 is a novel antiapoptotic protein that targets the BH3-only protein NOXA for degradation and whose inhibition extends survival in an ovarian cancer model.

P304

743-754

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425247.2012.683173

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22657869

http://www.w3.org/2001/XMLSchema#string

P921

nanocarrier

ovarian cancer

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

about

P2860

P2860

Nanocarrier systems for delivery of siRNA to ovarian cancer tissues.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921